iChemVELOCITY Automated Urine Chemistry System

K171083 · Iris Diagnostics, A Division of Iris International, Inc. · JIL · May 12, 2017 · Clinical Chemistry

Device Facts

Record IDK171083
Device NameiChemVELOCITY Automated Urine Chemistry System
ApplicantIris Diagnostics, A Division of Iris International, Inc.
Product CodeJIL · Clinical Chemistry
Decision DateMay 12, 2017
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 862.1340
Device ClassClass 2

Indications for Use

The iChem® VELOCITY™ automated urine chemistry system is an in vitro diagnostic device used to automate the urine chemistry analysis profile using iChem® VELOCITY ™ Urine Chemistry Strips. The iChemVELOCITY can be used as a stand-alone system, as well as in an iQ®200 Series system, a configuration given the proprietary name iRICELL™ as it is designed to be hardware and software compatible with iQ200 Series systems. It produces quantitative results for specific gravity; semi-quantitative results for glucose, blood, leukocyte esterase, bilirubin, urobilingen, pH, protein, ketones and ascorbic acid; and qualitative results for nitrites, color and clarity. iChemVELOCITY strips are intended for use only with the iChem Velocity analyzer. In particular, they are not intended for visual reading. The iChemVELOCITY is not intended to be used as a Point of Care (POC) analyzer. These measurements are used to aid in the diagnosis of metabolic disorders, kidney function anomalies, urinary tract infections, and liver function. Tests performed using the iChemVELOCITY are intended for clinical laboratory and in vitro diagnostic use only.

Device Story

Automated urine chemistry analyzer; processes urine samples via test strips and optical modules. Inputs: urine samples in test tubes; light reflectance from test strips; light transmittance/scattering through urine for color/clarity; refractive index for specific gravity. Operation: Strip Reader Module (SRM) measures reflectance; Color/Clarity Module (CCM) measures light transmission/scattering via color sensor; Specific Gravity Module (SGM) measures refractive index. Output: quantitative specific gravity; semi-quantitative chemistry results; qualitative color/clarity. Used in clinical laboratories; operated by lab personnel. Output displayed to clinicians to aid diagnosis of metabolic, renal, urinary, and liver conditions. Design change involves replacing end-of-life color sensor (TCS230 to TCS3200) and scatter LED, with updated firmware algorithm for color detection.

Clinical Evidence

Bench testing only. Method comparison and precision studies performed. Method comparison evaluated color/clarity results against the predicate; precision studies (n=240 per level) demonstrated high exact agreement (95-100%) and 100% agreement within ±1 block for all color and clarity categories.

Technological Characteristics

Automated urine chemistry analyzer. CCM utilizes Taos TCS3200 color sensor and Luxeonstar/Lumileds SR-01-WC100 scatter LED. Specific gravity measured via refractive index. SRM measures light reflectance. Microcontroller (PIC 18F25) uses UART communication. Firmware implements color detection using HSL color space and Ohta Color plane. Powered by internal switching mode power supply (AC to DC).

Indications for Use

Indicated for clinical laboratory use to automate urine chemistry analysis in patients requiring diagnosis of metabolic disorders, kidney function anomalies, urinary tract infections, and liver function. Not for Point of Care (POC) use.

Regulatory Classification

Identification

A urinary glucose (nonquantitative) test system is a device intended to measure glucosuria (glucose in urine). Urinary glucose (nonquantitative) measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, hypoglycemia, and hyperglycemia.

Related Devices

Submission Summary (Full Text)

{0} 1 # 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION ## TRIAGE-QUICK REVIEW DECISION SUMMARY 510(k) #: k171083 This 510(k) was reviewed under OIR’s Triage-Quick Review Program. This program represents an internal workload management tool intended to reduce internal FDA review resources for 510(k) applications that are of good quality upon receipt by FDA. The information in the 510(k) is complete and supports a substantial equivalence (SE) determination. Please refer to the applicant’s 510(k) summary for a summary of the information that supports this SE determination.
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...